Aggregation & Impurities

As the industry advances biotherapeutic development, the formulation and development functions play important roles, supporting the selection and optimization of molecules with better developability, stability, safety, and efficacy. The popular Aggregation & Impurities pipeline presents case studies of the latest tools, technologies, and cutting-edge approaches on detection and control of emerging contaminants, particles, product and process-related impurities, protein aggregates, and immunogenicity issues related to the progression of biologics into the development of high-quality biotherapeutic products.

January 19-20

Detection and Characterization of Particulates and Impurities

January 20-21

Protein Aggregation and Emerging Analytical Tools